HighTower Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $403K | Sell |
|
|||||
|
2025
Q1 | $499K | Buy |
|
|||||
|
2024
Q4 | $772K | Sell |
|
|||||
|
2024
Q3 | $647K | Buy |
|
|||||
|
2024
Q2 | $255K | Buy |
|
|||||
|
2024
Q1 | $489K | Sell |
|
|||||
|
2023
Q4 | $382K | Sell |
|
|||||
|
2023
Q3 | $608K | Sell |
|
|||||
|
2023
Q2 | $1.48M | Buy |
|
|||||
|
2023
Q1 | $1.8M | Buy |
|
|||||
|
2022
Q4 | $3.24M | Sell |
|
|||||
|
2022
Q3 | $5.64M | Sell |
|
|||||
|
2022
Q2 | $4.79M | Buy |
|
|||||
|
2022
Q1 | $6.17M | Buy |
|
|||||
|
2021
Q4 | $7.14M | Buy |
|
|||||
|
2021
Q3 | $274K | Sell |
|
|||||
|
2021
Q2 | $421K | Buy |
|
|||||
|
2021
Q1 | $418K | Sell |
|
|||||
|
2020
Q4 | $578K | Sell |
|
|||||
|
2020
Q3 | $368K | Sell |
|
|||||
|
2020
Q2 | $364K | Sell |
|
|||||
|
2020
Q1 | $279K | Buy |
|
|||||
|
2019
Q4 | $313K | Sell |
|
|||||
|
2019
Q3 | $485K | Buy |
|
|||||
|
2019
Q2 | $523K | Buy |
|
|||||
|
2019
Q1 | $445K | Sell |
|
|||||
|
2018
Q4 | $792K | Sell |
|
|||||
|
2018
Q3 | $1.55M | Buy |
|
|||||
|
2018
Q2 | $341K | Buy |
|
|||||
|
2018
Q1 | $237K | Buy |
|
|||||
|
2017
Q4 | $201K | Sell |
|
|||||
|
2017
Q3 | $198K | Sell |
|
|||||
|
2017
Q2 | $259K | Sell |
|
|||||
|
2017
Q1 | $206K | Buy |
|
|||||
|
2016
Q4 | $120K | Buy |
|
|||||
|
2016
Q3 | $144K | Buy |
|
|||||
|
2016
Q2 | $178K | Sell |
|
|||||
|
2016
Q1 | $193K | Buy |
|
|||||
|
2015
Q4 | $187K | Buy |
|
|||||
|
2015
Q3 | $110K | Buy |
|
|||||
|
2015
Q2 | $145K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $155K | Buy |
|